Skip links
Orsini Now Dispensing Boehringer Ingelheim’s JASCAYD® (nerandomilast) for the treatment of IPF. Learn more →
Pay My Bill
Prescribe a Therapy
Orsini
News & Resources

Orsini News & Resources

  • All
  • Blog Posts
  • In the News
  • Videos
  • White Papers
October 20, 2025

Orsini Launches Integrated Specialty Pharmacy and 3PL Solution at Facility in Columbus, Ohio

October 14, 2025

Orsini Selected as Specialty Pharmacy Partner for Boehringer Ingelheim’s JASCAYD® (nerandomilast)

September 26, 2025

Orsini Selected as Specialty Pharmacy Partner for Crinetics’ PALSONIFY™ (paltusotine)

September 3, 2025

Orsini and Paynela Partner to Expand Affordability and Copay/Coinsurance Support Programs for Rare Disease Patients

August 25, 2025

Orsini Selected as Exclusive Specialty Pharmacy Partner for Ionis’ DAWNZERA™ (donidalorsen)

July 30, 2025

Orsini Selected as Specialty Pharmacy Partner for PTC Therapeutics’ SEPHIENCE™ (sepiapterin)

July 7, 2025

Orsini Selected as Specialty Pharmacy Partner for KalVista’s EKTERLY® (sebetralstat)

April 25, 2025

Orsini Expands Biopharma Solutions with ORBIT Track™ to Enhance Partner Collaboration and Patient Case Management

April 1, 2025

Orsini Selected as the Exclusive Specialty Pharmacy for Cell Therapy ENCELTO™

February 20, 2025

Specialty Pharmacy Continuum—Rare Disease Pharmacies: The Quarterbacks for Orphan Drug Regimens

January 14, 2025

Orsini the Exclusive Specialty Pharmacy Provider for Gene Therapy KEBILIDI (eladocagene exuparvovec-tneq)

January 7, 2025

Orsini and PicnicHealth Partner to Improve Rare Disease Patient Care and Real-World Study Execution

December 9, 2024

Orsini chosen by Ascendis to distribute treatment for rare endocrine disorder in the U.S.

November 25, 2024

Orsini Chosen by BridgeBio as a Specialty Pharmacy Provider for ATTRUBY™ (acoramidis), for the Treatment of Cardiomyopathy of Transthyretin-Mediated Amyloidosis

November 14, 2024

Orsini Now Distributing CASGEVY® (exagamglogene autotemcel), a Gene-Editing Therapy

November 5, 2024

Orsini Now a Specialty Pharmacy Provider for SAJAZIR™ (icatibant) Injection, to Treat Acute HAE Attacks

October 21, 2024

Orsini Is Now a Specialty Pharmacy Provider for FUROSCIX® (furosemide injection), an Infused Diuretic for Congestive Heart Failure

October 3, 2024

Orsini Launches ORBIT™ (Orsini Rare Business Intelligence Technology) to Enhance Rare Disease Patient Care

September 24, 2024

Orsini Chosen as the Exclusive Specialty Pharmacy Provider for MIPLYFFA™ (arimoclomol), the First FDA-Approved Treatment for Niemann-Pick Disease Type C

September 19, 2024

[Video] Rare Disease Patient Management

September 3, 2024

Specialty Pharmacy Continuum: Specialty Pharmacies’ Role in Gene Therapy

August 15, 2024

Orsini Now Dispensing Livdelzi (seladelpar), for Treatment of Rare Liver Disease

June 18, 2024

Zevra Therapeutics Transitions to Orsini as the Specialty Pharmacy Provider for OLPRUVA® (sodium phenylbutyrate), a Treatment for Certain Urea Cycle Disorders

June 2, 2024

What is a Specialty Pharmacy?

May 19, 2024

[Video] Gene Therapy Patient Case Management

May 3, 2024

Specialty Pharmacy Continuum: Gene Therapy a Hot Trend in Cold Chain

April 18, 2024

Orsini Announcement: Orsini Specialty Pharmacy Chosen to Dispense YARGESA (miglustat)

April 17, 2024

Optimizing Patient Care in Rare Hematologic Conditions: Novel Therapies in Classical Hematology and the Role of Specialty Pharmacy in Driving Enhanced Outcomes

April 4, 2024

Orsini Announcement: Orsini Specialty Pharmacy Welcomes Two Executive Leadership Hires

April 1, 2024

Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy

March 31, 2024

Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder

March 30, 2024

Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease

March 20, 2024

Orsini Specialty Pharmacy Names Darin DeCarlo Chief Growth Officer

March 20, 2024

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ™ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease

March 20, 2024

Orsini Selected by BioMarin to Dispense ROCTAVIAN™, the First Gene Therapy for the Treatment of Severe Hemophilia A

March 20, 2024

Orsini selected as the exclusive specialty pharmacy for WAINUA (eplontersen) for adults with hereditary transthyretin-mediated amyloid polyneuropathy

March 20, 2024

Now In Stock: ADZYNMA (ADAMTS13, recombinant-krhn), for patients with cTTP

March 20, 2024

Orsini Specialty Pharmacy Selected as Distribution Partner for Adzynma (ADAMTS13, recombinant-krhn), a Newly Approved Treatment for an Ultra-Rare Blood Clotting Disorder

March 20, 2024

Orsini Specialty Pharmacy Partners with Amicus Therapeutics to Dispense New Therapy for the Treatment of Late-Onset Pompe Disease

March 19, 2024

Medical Benefits Billing for Specialty Therapies

March 19, 2024

Orsini Specialty Pharmacy Selected by Marinus Pharmaceuticals as the Exclusive Specialty Pharmacy Partner for ZTALMY®

March 19, 2024

Payor Considerations When Evaluating a Specialty Pharmacy Partner

March 19, 2024

Orsini Specialty Pharmacy Earns Rare Disease Pharmacy Center of Excellence Designation from URAC

March 19, 2024

Orsini Specialty Pharmacy Selected as part of the Limited Specialty Pharmacy Network For VYJUVEK™

March 19, 2024

Orsini Specialty Pharmacy Now Dispensing VOWST™ (fecal microbiota spores, live – brpk)

March 19, 2024

[eBook] Living with Duchenne Muscular Dystrophy (DMD): Tommy’s Story

March 19, 2024

[Video] The Value of a Specialty Pharmacy Partner for Manufacturers

March 19, 2024

[eBook] Living with Spinal Muscular Atrophy: Sienna & Wesley’s Stories

March 19, 2024

Gene Therapy Guides Future Treatment for Rare Diseases

February 28, 2024

Choosing a Specialty Pharmacy to Support Mucopolysaccharidosis (MPS) Patients

January 22, 2024

Choosing a Specialty Pharmacy to Support Tardive Dyskinesia Patients

January 19, 2024

Six Ways the Right Specialty Pharmacy Partner Helps Improve Medication Adherence

December 9, 2023

Choosing a Specialty Pharmacy to Support Patients with Recurrent Pericarditis

December 1, 2023

Six Ways to Help Patients Manage Rare Diseases

November 27, 2023

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for Evkeeza™

November 19, 2023

Orsini Specialty Pharmacy Selected by Glaukos® Corporation as a Specialty Distribution Partner for Photrexa® and Photrexa® Viscous

November 19, 2023

7 Ways to Support Caregivers During National Family Caregivers Month

November 3, 2023

7 Factors Payors Should Consider When Choosing a Specialty Pharmacy Partner

November 1, 2023

Rare Disease Day: Raising Awareness for Patients Living with Rare Diseases

October 25, 2023

How to Manage the Administrative Burden of Prior Authorization

October 19, 2023

Orsini Specialty Pharmacy Selected as a Limited Distribution Partner for AMVUTTRA™ (vutrisiran)

October 19, 2023

Choosing a Specialty Pharmacy to Support Spinal Muscular Atrophy

October 11, 2023

How to Manage the Administrative Burden of Prior Authorization

October 6, 2023

Choosing a Specialty Pharmacy to Support Hereditary ATTR Amyloidosis Patients

October 6, 2023

Orsini Specialty Pharmacy Selected by Sarepta Therapeutics as a Limited Distribution Partner for AMONDYS 45 (casimersen)

October 1, 2023

Importance of Hand Hygiene in Healthcare: Handwashing Awareness Week

September 11, 2023

Choosing a Specialty Pharmacy to Support Idiopathic Pulmonary Fibrosis Patients

September 10, 2023

Choosing a Specialty Pharmacy to Support Spinal Muscular Atrophy

August 7, 2023

5 Services Providers Should Expect from a Specialty Pharmacy

August 5, 2023

Orsini Specialty Pharmacy Selected by Alnylam® Pharmaceuticals as Limited Distribution Partner for OXLUMO™

July 29, 2023

3 Proven Ways to Help Patients Manage the Costs of Specialty Medications for Rare Conditions

July 22, 2023

What Makes Orsini Special? Meet Our Specialty Pharmacists

July 22, 2023

[Video] The Value of a Specialty Pharmacy Partner for Manufacturers

July 21, 2023

Five Ways to Define and Redefine Rare Diseases

July 17, 2023

Six Reasons the Specialty Pharmacist Role is Increasingly Important

July 9, 2023

Choosing a Specialty Pharmacy to Support Hereditary Angioedema

July 3, 2023

Choosing a Specialty Pharmacy to Support Duchenne Muscular Dystrophy

June 28, 2023

[Patient Story] Living with Hereditary ATTR amyloidosis: Dennis’ Story

June 21, 2023

Orsini Specialty Pharmacy Selected by Glaukos® Corporation as a Specialty Distribution Partner for Photrexa® and Photrexa® Viscous

June 19, 2023

Importance of the ACHC Distinction in Rare Diseases and Orphan Drugs for a Specialty Pharmacy Partner

May 30, 2023

The Burden of Prior Authorizations: How Specialty Pharmacies Can Help

May 8, 2023

Choosing a Specialty Pharmacy to Support Pompe Disease Patients

May 1, 2023

8 Facts to Know About Mucopolysaccharidosis on MPS Awareness Day

April 17, 2023

Six Ways Orsini Ensures No Patient is Left Behind

April 8, 2023

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for Evkeeza™

March 19, 2023

Orsini Specialty Pharmacy Selected by PTC Therapeutics as a Limited Distribution Partner for EMFLAZA® (deflazacort)

March 16, 2023

7 Helpful Facts to Raise Awareness for Duchenne Muscular Dystrophy (DMD)

February 12, 2023

Rare Disease Day: Raising Awareness for Patients Living with Rare Diseases

February 1, 2023

Rare Disease Day: In Loving Memory of Tommy

January 22, 2023

Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD

January 19, 2023

Rare Disease Day: A Reminder of Our Immense Responsibility to Serve Patients and Families

January 6, 2023

Orsini Selected by Sarepta Therapeutics to Dispense ELEVIDYS (delandistrogene moxeparvovec-rokl), the First Gene Therapy to Treat Duchenne Muscular Dystrophy

December 3, 2022

6 Important Facts to Know About Hereditary Angioedema

November 5, 2022

Patients Share Their Journeys Living with Rare & Complex Diseases

September 17, 2022

Clinical & Operational Services to Consider When Selecting a Specialty Pharmacy Partner

August 25, 2022

Pharmaceutical Manufacturer & Payor Expectations When Partnering with a Specialty Pharmacy

July 12, 2022

COVID-19 Lengthens the Journey to Health Equity for Rare Disease Patients

June 9, 2022

Demystifying Four Common Pain Points for Patients Living with Rare Diseases

June 4, 2022

6 Facts About Alzheimer’s Disease

May 11, 2022

Choosing a Specialty Pharmacy to Support Patients with X-linked hypophosphatemia

May 1, 2022

Orsini Specialty Pharmacy Selected to Dispense Aduhelm™ for the Treatment of Alzheimer’s Disease

April 29, 2022

Communication & Collaboration Between a Pharmaceutical Manufacturer and Specialty Pharmacy

March 9, 2022

Orsini Salutes Healthcare Quality Week

March 1, 2022

Choosing a Specialty Pharmacy to Support ERT Therapies

March 1, 2022

[Video] How a Specialty Pharmacy Can Make All the Difference for Patients

March 1, 2022

Orsini Specialty Pharmacy Offers Patients Access to Generic Treatment for Severe Homozygous Cystinuria

February 22, 2022

Dietary Guidelines: Gaucher Disease Type 1 Patients Taking Miglustat

February 1, 2022

[Video] Rare Disease Day: What’s Your Why

January 10, 2022

7 Common Characteristics of a Specialty Drug

December 19, 2021

6 Metrics to Track Specialty Pharmacy Patient Satisfaction

October 19, 2021

Living with Duchenne Muscular Dystrophy: Tommy’s Poem

September 19, 2021

Three Reasons Why Newborn Screening Awareness Month is More Important than Ever

September 19, 2021

Orsini Specialty Pharmacy Selected By Sanofi As A Limited Distribution Partner For Nexviazyme®

September 11, 2021

7 Facts to Know About DMD on World Duchenne Awareness Day

September 5, 2021

7 Facts About Rare Diseases to Raise Awareness on Rare Disease Day

June 11, 2021

Tackling the Challenge of Health Literacy, One Word at a Time

May 9, 2021

5 Ways COVID-19 Impacts Immunocompromised & Rare Disease Patients

February 10, 2021

3 Opportunities for Patients with Rare & Complex Diseases in the Time of COVID-19